drugset / Trial / NCT06263998
Clinical Study for the Evaluation of Safety and Tolerability of NCP112 Eye Drops
RandomizedParallel-groupDouble-blindTreatment
Summary
The objective is to evaluate the safety, local tolerability, and pharmacokinetics of NCP112 eye drops through single and multiple dose-escalation ocular administrations in healthy adults.
Timeline
- Start
- 2024-07-11
- Primary completion
- 2025-11-28
- Completion
- 2026-01-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NCP112 | Unknown | — | Topical |